Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Current Partnering | PRODUCT CODE: 2055568

Cover Image

PUBLISHER: Current Partnering | PRODUCT CODE: 2055568

Diagnostic Imaging Collaboration and Licensing Deals 2016-2026

PUBLISHED:
PAGES: 400+ Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3995
PDF (Multi User License - 2 to 5 Users)
USD 5995
PDF (Company Wide License)
USD 7995

Add to Cart

The definitive benchmark for diagnostic imaging dealmaking

Diagnostic imaging partnering is driven by advanced imaging technologies and integrated software platforms, with deal structures reflecting the combination of hardware, data, and clinical workflow solutions.

This report provides a comprehensive and structured analysis of 710+ diagnostic imaging collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how diagnostic imaging deals are structured in practice, allowing you to:

  • Benchmark comparable transactions with confidence
  • Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
  • Define realistic market parameters
  • Clear insight into how deal terms vary by imaging modality, software integration, and partner profile
  • Support valuation and structuring decisions with evidence
  • Ground internal discussions in real transaction data rather than assumptions
  • Understand how leading companies approach dealmaking
  • Visibility into partner behaviour and recurring deal structures across a technology-integrated and clinically embedded landscape
  • Full visibility into deal structure and execution
  • Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

  • Rights granted and retained
  • Development and commercialization responsibilities
  • Financial structures and payment triggers
  • Key contractual provisions and protections
  • This level of transparency is critical to understanding how value, risk, and control are allocated within diagnostic imaging partnerships, particularly where hardware, software, and data integration are central to the collaboration.
  • Designed for real-world BD and strategy use

The report is widely used to:

  • Structure and benchmark imaging and technology-driven transactions
  • Prepare for negotiations with well-defined market context
  • Evaluate platform, software, and collaboration partners
  • Support internal strategy with robust, defensible data
  • What's included
  • 710+ diagnostic imaging collaboration and licensing deals
  • Financial terms, including upfronts, milestones, and royalties where disclosed
  • Fully searchable deal directory (by company, modality, and application)
  • Direct access to SEC-filed agreements and source documents
  • Analysis of deal trends, key transactions, and active dealmakers
  • A trusted, evidence-based reference for diagnostic imaging dealmaking
  • Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how diagnostic imaging partnerships are structured, negotiated, and valued.
Product Code: CP21041

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in diagnostic imaging dealmaking

  • 2.1. Introduction
  • 2.2. Diagnostic imaging deals over the years
  • 2.3. Most active diagnostic imaging dealmakers
  • 2.4. Diagnostic imaging deals by deal type
  • 2.5. Diagnostic imaging deals by therapy area
  • 2.6. Diagnostic imaging deals by industry sector
  • 2.7. Deal terms for diagnostic imaging deals
    • 2.7.1 Diagnostic imaging deals headline values
    • 2.7.2 Diagnostic imaging deal upfront payments
    • 2.7.3 Diagnostic imaging deal milestone payments
    • 2.7.4 Diagnostic imaging royalty rates

Chapter 3 - Leading diagnostic imaging deals

  • 3.1. Introduction
  • 3.2. Top diagnostic imaging deals by value

Chapter 4 - Most active diagnostic imaging dealmakers

  • 4.1. Introduction
  • 4.2. Most active diagnostic imaging dealmakers
  • 4.3. Most active diagnostic imaging deals company profiles

Chapter 5 - Diagnostic imaging contracts dealmaking directory

  • 5.1. Introduction
  • 5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 - Diagnostic imaging dealmaking by technology type

  • Deal directory
  • Deal directory - Diagnostic imaging deals by company A-Z
  • Deal directory - Diagnostic imaging deals by deal type
  • Deal directory - Diagnostic imaging deals by therapy area
  • Deal type definitions
  • About Biopharma Research Ltd
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

Table of figures

  • Figure 1: Diagnostic imaging deals since 2016
  • Figure 2: Active diagnostic imaging dealmaking activity since 2016
  • Figure 3: Diagnostic imaging deals by deal type since 2016
  • Figure 4: Diagnostic imaging deals by therapy area since 2016
  • Figure 5: Diagnostic imaging deals by industry sector since 2016
  • Figure 6: Diagnostic imaging deals with a headline value
  • Figure 7: Diagnostic imaging deals with an upfront value
  • Figure 8: Diagnostic imaging deals with a milestone value
  • Figure 9: Diagnostic imaging deals with a royalty rate value
  • Figure 10: Top diagnostic imaging deals by value since 2016
  • Figure 11: Most active diagnostic imaging dealmakers since 2016
  • Figure 12: Diagnostic imaging deals by technology type since 2016
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!